LTS Lohmann Therapie-Systeme Overview
- Year Founded
-
1984
- Status
-
Acquired/Merged
- Employees
-
2,000
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
4
LTS Lohmann Therapie-Systeme General Information
Description
Provider of drug delivery systems intended for the pharmaceutical industry. The company's technology utilizes transdermal patches, oral thin films, and microneedle array patches, enabling pharmaceutical partners to develop and manufacture non-invasive delivery solutions for small molecules, biologics, and vaccines through integrated contract development and manufacturing services.
Contact Information
Website
www.ltslohmann.comCorporate Office
- Lohmannstraße 2
- 56626 Andernach
- Germany
Corporate Office
- Lohmannstraße 2
- 56626 Andernach
- Germany
LTS Lohmann Therapie-Systeme Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
LTS Lohmann Therapie-Systeme Comparisons
Industry
Financing
Details
LTS Lohmann Therapie-Systeme Competitors (14)
One of LTS Lohmann Therapie-Systeme’s 14 competitors is Corium International, a Private Equity-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Corium International | Private Equity-Backed | Cambridge, MA | ||||
| Prosolus | Venture Capital-Backed | Miami, FL | ||||
| Nualtis | Corporate Backed or Acquired | Saint-Laurent, Canada | ||||
| Medherant | Venture Capital-Backed | Coventry, United Kingdom | ||||
| Nemera | Private Equity-Backed | Lyon, France |
LTS Lohmann Therapie-Systeme Patents
LTS Lohmann Therapie-Systeme Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026219740-A1 | Agomelatine transmucosal therapeutic system for use in a method of treating a human subject | Pending | 15-Apr-2025 | ||
| WO-2026219784-A1 | Transmucosal therapeutic system containing agomelatine | Pending | 15-Apr-2025 | ||
| WO-2026209656-A1 | Transdermal therapeutic system comprising cytisine | Pending | 31-Mar-2025 | ||
| EP-4813437-A1 | Method and system for manufacturing a microneedle array, as well as carrier and microneedle array | Pending | 28-Mar-2025 | ||
| WO-2026202412-A1 | Method and system for manufacturing a microneedle array, as well as carrier and microneedle array | Pending | 28-Mar-2025 | A61M37/0015 |
LTS Lohmann Therapie-Systeme Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LTS Lohmann Therapie-Systeme Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
LTS Lohmann Therapie-Systeme Investments & Acquisitions (4)
LTS Lohmann Therapie-Systeme’s most recent deal was a Buyout/LBO with Renaissance Lakewood. The deal was made on 07-Nov-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Renaissance Lakewood | 07-Nov-2025 | Buyout/LBO | Pharmaceuticals | ||
| Sorrel Medical | 08-Jun-2023 | Merger/Acquisition | Other Devices and Supplies | ||
| Micron Biomedical | 25-Nov-2022 | Later Stage VC | Drug Discovery | ||
| Tapemark | 19-Aug-2022 | Buyout/LBO | BPO/Outsource Services |
LTS Lohmann Therapie-Systeme Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Iis Innovative Injektions-Systeme Verwaltungs | Andernach, Germany | 2010 | |
| Renaissance Lakewood | Lakewood, NJ | 2000 | |
| Lts Therapy Systems | Saint Paul, MN | 1955 |
LTS Lohmann Therapie-Systeme FAQs
-
When was LTS Lohmann Therapie-Systeme founded?
LTS Lohmann Therapie-Systeme was founded in 1984.
-
Where is LTS Lohmann Therapie-Systeme headquartered?
LTS Lohmann Therapie-Systeme is headquartered in Andernach, Germany.
-
What is the size of LTS Lohmann Therapie-Systeme?
LTS Lohmann Therapie-Systeme has 2,000 total employees.
-
What industry is LTS Lohmann Therapie-Systeme in?
LTS Lohmann Therapie-Systeme’s primary industry is Drug Delivery.
-
Is LTS Lohmann Therapie-Systeme a private or public company?
LTS Lohmann Therapie-Systeme is a Private company.
-
What is LTS Lohmann Therapie-Systeme’s current revenue?
The current revenue for LTS Lohmann Therapie-Systeme is .
-
Who are LTS Lohmann Therapie-Systeme’s investors?
BWK, Dievini, and Novartis have invested in LTS Lohmann Therapie-Systeme.
-
Who are LTS Lohmann Therapie-Systeme’s competitors?
Corium International, Prosolus, Nualtis, Medherant, and Nemera are some of the 14 competitors of LTS Lohmann Therapie-Systeme.
-
When was LTS Lohmann Therapie-Systeme acquired?
LTS Lohmann Therapie-Systeme was acquired on 01-Jul-2025.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
